Rakovina Therapeutics adds Petra Hamerlik to board as Jeffrey Bacha retires

• Rakovina Therapeutics named Dr. Petra Hamerlik to its board following the Aug. 18, 2026 annual shareholder meeting.
• Jeffrey Bacha retired from the board, continuing with the company in an advisory capacity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rakovina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608190400PRIMZONEFULLFEED9812518) on August 19, 2026, and is solely responsible for the information contained therein.